Quetiapine Fumarate Tablet
Product Images NDC 60687-327

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 60687-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Blister

Sheet of multiple Quetiapine 100 mg tablets labels from American Health Packaging. Each label includes the proprietary name, dosage strength, tablet form, UPC barcode, lot number, and expiration date placeholders. The labels are arranged in two columns and five rows on a white background.*

FDA Label Image

100 mg Carton

Quetiapine Tablets USP 100 mg tablet label showing packaging details for 100 tablets (10 x 10). The label includes dispensing instructions, storage conditions, dosage form, and manufacturer information for American Health Packaging, Columbus, Ohio. The NDC number 60687-349-01 appears twice on the label.*

FDA Label Image

200 mg Blister

Label sheet showing multiple identical Quetiapine fumarate 200 mg oral tablets labels from American Health Packaging. Each label includes product name, strength, dosage form, barcodes, placeholder sections for expiry date and lot number, and the manufacturer's location in Columbus, Ohio.*

FDA Label Image

200 mg Carton

Quetiapine 200 mg tablets USP in a 100-tablet package (10 x 10), labeled for prescription use only. The label includes barcodes, National Drug Code (NDC) 60687-360-01, and dispensing instructions for pharmacists. It notes the active ingredient strength and storage conditions, with distribution by American Health Packaging, Columbus, Ohio.*

FDA Label Image

25 mg Blister

Quetiapine fumarate 25 mg oral tablet labels from American Health Packaging. The labels display the product name, strength, barcode, expiration date, lot number, and manufacturer information for batch tracking and identification. Each label appears identical, arranged in a grid layout on a single sheet.*

FDA Label Image

25 mg Carton

Label for Quetiapine Tablets USP 25 mg, oral tablets, containing 100 tablets (10 x 10) in the package. The label displays the National Drug Code 60687-327-01 and indicates the tablets are Rx only. It includes dosing, storage instructions, pharmacist dispensing note, and distributor information for American Health Packaging, Columbus, Ohio.*

FDA Label Image

300 mg Blister

Packaging labels for Quetiapine fumarate 300 mg tablets, oral dosage form. Each label includes the product name Quetiapine Tablet USP 300 mg, a barcode, placeholders for lot number and expiry date, and the labeler information American Health Packaging, Columbus, Ohio.*

FDA Label Image

300 mg Carton

Label for Quetiapine Tablets USP 300 mg, containing 100 tablets (10 x 10) for oral use, distributed by American Health Packaging. The label includes the NDC 60687-371-01 and instructions to dispense the accompanying Medication Guide to each patient. It notes each tablet contains 345.36 mg quetiapine fumarate equivalent to quetiapine 300 mg, plus storage and usage information.*

FDA Label Image

400 mg Blister

Labels for Quetiapine Tablet USP 400 mg oral tablets by American Health Packaging. Each label includes the product name, strength, a barcode, lot number, expiration date, and the manufacturer location in Columbus, Ohio.*

FDA Label Image

400 mg Carton

Quetiapine fumarate 400 mg tablets USP, oral dosage form, in a package containing 100 tablets (10 blister packs of 10). Label includes NDC 60687-382-01, prescribing and storage information, and distributor American Health Packaging, Columbus, Ohio.*

FDA Label Image

50 mg Blister

Label sheet showing multiple identical labels for Quetiapine fumarate tablets USP 50 mg, each featuring the product name, strength, dosage form, 50 mg strength, a barcode, expiration and lot number placeholders, and the labeler American Health Packaging, Columbus, Ohio.*

FDA Label Image

50 mg Carton

Quetiapine tablets USP 50 mg oral tablets in a package containing 100 tablets (10 blister cards of 10 tablets each). The label includes the NDC 60687-338-01, indicates prescription-only status, and provides storage instructions. The labeler is American Health Packaging.*

FDA Label Image

Ahp32701

Pink, round oral tablet imprinted with "LU" on one side and "Y 15" on the other. The tablet is identified as Quetiapine fumarate, a human prescription drug available in multiple strengths, labeled by American Health Packaging.*

FDA Label Image

Ahp33801

Quetiapine fumarate 100 mg round white tablet with imprint 'Y16' on one side and 'LU' on the other side. The image shows both tablet faces. Labeler is American Health Packaging.*

FDA Label Image

Ahp34901

Quetiapine fumarate 100 mg oral tablet in round, yellow form. One side is imprinted with 'LU' and the other side with 'Y17'. Labeler is American Health Packaging. The image shows the tablet's size, shape, color, and imprint for identification purposes.*

FDA Label Image

Ahp36001

Quetiapine fumarate 100 mg tablet, round and white, with imprint 'Y18' on one side and 'LU' on the other, for oral use. Manufactured by American Health Packaging.*

FDA Label Image

Ahp37101

Quetiapine fumarate 100 mg oral tablet prescribed for human use, manufactured by American Health Packaging. The white, oblong tablet is imprinted with 'Y19' on one side and 'LU' on the other, representing this specific product and strength.*

FDA Label Image

Ahp38201

Quetiapine fumarate 200 mg oral tablets by American Health Packaging. The oblong, yellow tablets are debossed with 'LU' on one side and 'Y20' on the other, corresponding to the 200 mg strength. The image shows the tablet's shape, color, and imprint details for identification.*

FDA Label Image

Figure 1

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two groups are compared: a dashed line representing QTP+LI/VAL and a solid line representing PLA+LI/VAL. The graph illustrates relapse rates increasing with time for both groups, with PLA+LI/VAL group showing a higher proportion of relapse than the QTP+LI/VAL group over 100 weeks.*

FDA Label Image

Figure 2

A Kaplan-Meier curve depicting the proportion of patients with relapse (%) over time in weeks. The graph compares two treatment groups labeled as QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line), showing the cumulative relapse rates during the observation period up to 100 weeks.*

FDA Label Image

Structure

Chemical structure diagram of quetiapine fumarate, depicting the molecular arrangement of the active ingredient and its fumarate salt form. The structure shows two parts: the quetiapine molecule and the fumarate ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.